Ion Exchange Eyes ₹2,500+ Crore Order Book, Focuses on Water Treatment Expansion
Ion Exchange (India) Limited aims for an order book exceeding ₹2,500 crores, focusing on industrial and municipal water treatment projects. The company is investing in R&D and membrane manufacturing to expand its sustainable water-tech solutions portfolio. As of September 30, 2025, Ion Exchange reported a total order book of ~₹2,711 Cr and a bid pipeline of ~₹9,011 Cr. The company's Q2 FY26 consolidated results show an operating income of ₹7,339 Mn and a net profit of ₹499 Mn. Ion Exchange has partnered with MANN+HUMMEL for membrane manufacturing and started commissioning its new resin plant in Maharashtra.

*this image is generated using AI for illustrative purposes only.
Ion Exchange (India) Limited , a pioneer in water and environment solutions, has set its sights on a robust order book exceeding ₹2,500 crores, with a strategic focus on industrial and municipal water treatment projects. The company is emphasizing key growth areas including exports, desalination, and zero-liquid-discharge systems to drive its expansion.
Strategic Growth Initiatives
Ion Exchange is actively investing in research and development, along with membrane manufacturing, to broaden its portfolio of sustainable water-tech solutions. This move is aimed at strengthening the company's global presence and cementing its position as a leader in the water treatment industry.
Financial Performance
According to the company's recent earnings presentation for Q2/H1-FY26:
| Metric | Q2 FY26 (Consolidated) | H1 FY26 (Consolidated) |
|---|---|---|
| Operating Income | ₹7,339 Mn | ₹13,171 Mn |
| Operating EBITDA | ₹685 Mn | ₹1,310 Mn |
| Operating EBITDA Margin | 9.33% | 9.95% |
| Net Profit | ₹499 Mn | ₹984 Mn |
| PAT Margin | 6.80% | 7.47% |
| Diluted EPS | ₹4.18 | ₹8.29 |
The company has shown growth in its operating income and maintained stable profitability margins in the first half of FY26.
Order Book and Business Segments
As of September 30, 2025, Ion Exchange reported:
- Total Order Book: ~₹2,711 Cr
- Engineering Projects: ~₹2,269 Cr
- Outstanding Sri Lanka Order: ~₹104 Cr
- Outstanding UP Jal Nigam Order: ~₹338 Cr
- Bid Pipeline: ~₹9,011 Cr
The company's business is divided into three main segments:
- Engineering (61% of revenue): Provides comprehensive water and wastewater treatment solutions.
- Chemicals (29% of revenue): Offers resins, specialty chemicals, and chemical treatment programs.
- Consumer Products (10% of revenue): Caters to various establishments with safe drinking water solutions.
Recent Developments
- Ion Exchange has entered a strategic partnership with MANN+HUMMEL Water & Membrane Solutions to manufacture Hollow-Fiber Ultrafiltration (UF) and Membrane Bioreactor (MBR) membranes in India.
- The company has commenced the stage-wise commissioning of its greenfield resin manufacturing plant at Roha, Maharashtra, enhancing its manufacturing capabilities.
Market Position
With a strong presence in both domestic (65%) and export (35%) markets, Ion Exchange continues to serve a diverse clientele including major industrial, institutional, and international customers.
As Ion Exchange expands its order book and focuses on technological advancements in water treatment, the company appears well-positioned to capitalize on the growing demand for water and wastewater management solutions both in India and globally.
Historical Stock Returns for Ion Exchange
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.74% | -4.06% | -4.52% | -22.36% | -45.46% | +106.22% |


































